Legislature(2025 - 2026)DAVIS 106
05/15/2025 03:15 PM House HEALTH & SOCIAL SERVICES
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| SB134 | |
| HB185 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| + | TELECONFERENCED | ||
| += | HB 185 | TELECONFERENCED | |
| += | HB 149 | TELECONFERENCED | |
| += | SB 134 | TELECONFERENCED | |
SB 134-PHARMACY BENEFITS MANAGER;3RD PARTY ADMIN
4:23:14 PM
CHAIR MINA announced that the first order of business would be
SENATE BILL NO. 134, "An Act relating to pharmacy benefits
managers; relating to third-party administrators; and providing
for an effective date."
4:23:42 PM
JANE ROHR, Staff, Senator Cathy Giessel, Alaska State
Legislature, presented SB 134 on behalf of Senator Giessel,
prime sponsor. She stated that pharmacy benefit managers and
third-party administrators do business as intermediaries
"between insurance companies and pharmacies or consumers." Some
responsibilities include the negotiation of medication prices
and the processing of claims. She continued:
Current statute requires these entities to be
registered, which only allows for a basic level of
recognition. The purpose of this bill is to require
transparency and accountability for third-party
administrators and pharmacy benefit managers operating
in the state of Alaska, by requiring them to be
licensed and subject to oversight by the Division of
Insurance.
MS. ROHR, in conclusion, offered to answered questions.
4:24:31 PM
CHAIR MINA noted those available for questions and entertained
amendments.
4:24:47 PM
REPRESENTATIVE RUFFRIDGE moved to adopt Amendment 1 to SB 134,
labeled 34-LS0461\A.2, Wallace, 5/14/25, which read as follows:
Page 16, following line 13:
Insert a new bill section to read:
"* Sec. 32. AS 21.36.520(a) is amended to read:
(a) An insurer providing a health care insurance
policy or its pharmacy benefits manager may not
(1) interfere with a covered person's right
to choose a pharmacy or provider;
(2) interfere with a covered person's right
of access to a clinician-administered drug;
(3) interfere with the right of a pharmacy
or pharmacist to participate as a network pharmacy;
(4) reimburse a pharmacy or pharmacist an
amount less than the amount the pharmacy benefits
manager reimburses an affiliate for providing the same
pharmacy services, calculated on a per-unit basis
using the same generic product identifier or generic
code number;
(5) impose a reduction in reimbursement for
pharmacy services because of the person's choice among
pharmacies that have agreed to participate in the plan
according to the terms offered by the insurer or its
pharmacy benefits manager;
(6) use a covered person's pharmacy
services data collected under the provision of claims
processing services for the purpose of soliciting,
marketing, or referring the person to an affiliate of
the pharmacy benefits manager;
(7) prohibit or limit a pharmacy from
mailing, shipping, or delivering drugs to a patient as
an ancillary service; however, the insurer or its
pharmacy benefits manager
(A) is not required to reimburse a delivery
fee charged by a pharmacy unless the fee is specified
in the contract between the pharmacy benefits manager
and the pharmacy;
(B) may not require a patient signature as
proof of delivery of a mailed or shipped drug if the
pharmacy
(i) maintains a mailing or shipping log
signed by a representative of the pharmacy or keeps a
record of each notification of delivery provided by
the United States mail or a package delivery service;
and
(ii) is responsible for the cost of
mailing, shipping, or delivering a replacement for a
drug that was mailed or shipped but not received by
the covered person;
(8) prohibit or limit a network pharmacy
from informing an insured person of the difference
between the out-of-pocket cost to the covered person
to purchase a drug, medical device, or supply using
the covered person's pharmacy benefits and the
pharmacy's usual and customary charge for the drug,
medical device, or supply;
(9) conduct or participate in spread
pricing in the state;
(10) assess, charge, or collect a form of
remuneration that passes from a pharmacy or a
pharmacist in a pharmacy network to the pharmacy
benefits manager, including claim processing fees,
performance-based fees, network participation fees, or
accreditation fees;
(11) reverse and resubmit the claim of a
pharmacy more than 90 days after the date the claim
was first adjudicated, and may not reverse and
resubmit the claim of a pharmacy unless the insurer or
pharmacy benefits manager
(A) provides prior written notification to
the pharmacy;
(B) has just cause;
(C) first attempts to reconcile the claim
with the pharmacy; and
(D) provides to the pharmacy, at the time
of the reversal and resubmittal, a written description
that includes details of and justification for the
reversal and resubmittal;
(12) prohibit or limit a pharmacy from
collecting a fee from a covered person for a service
or product not covered by the covered person's health
care insurance policy."
Renumber the following bill sections accordingly.
CHAIR MINA objected for the purpose of discussion.
REPRESENTATIVE RUFFRIDGE explained that there have been reports
of contracts or policies that do not allow a pharmacy to collect
a fee for additional services, such as delivery or adherence
packing, without risking termination of contract. The language
that would be added by adopting Amendment 1 would remedy that.
CHAIR MINA removed her objection.
4:26:10 PM
REPRESENTATIVE GRAY objected. He asked who would pay.
REPRESENTATIVE RUFFRIDGE clarified that Amendment 1 allows for a
service that is not already covered under the plan; therefore
the fee would be charged to the patient. In response to follow-
up questions from Representative Gray, Representative Ruffridge
noted that he, as a pharmacist, regularly mails prescriptions to
patients in remote areas or when items are difficult to obtain
from different locations. He noted that Amendment 1 would allow
a pharmacy to offer delivery service.
4:28:55 PM
REPRESENTATIVE GRAY removed his objection. There being no
further objection, Amendment 1 was adopted.
4:29:15 PM
REPRESENTATIVE GRAY moved to report SB 134, as amended, out of
committee with individual recommendations and the accompanying
fiscal notes. There being no objection, HCSSB 134(HSS) was
reported out of the House Health and Social Services Standing
Committee.
| Document Name | Date/Time | Subjects |
|---|---|---|
| HB 185 Response to HHSS 5.6.25.pdf.pdf |
HHSS 5/15/2025 3:15:00 PM |
HB 185 |
| HB 185 Supporting Document State of Alaska Bulletin 2021.pdf |
HHSS 5/15/2025 3:15:00 PM |
HB 185 |
| HB 185 Supporting Document-Alaska Beacon Article 5.14.2025.pdf |
HHSS 5/15/2025 3:15:00 PM |
HB 185 |
| HB 185 Supporting Document-BMJ Public Health Article 5.14.2025.pdf |
HHSS 5/15/2025 3:15:00 PM |
HB 185 |
| HB 185 Supporting Document-KFF Article 5.14.2025.pdf |
HHSS 5/15/2025 3:15:00 PM |
HB 185 |
| HB 185 Supporting Document State of Alaska Epidemiology Bulletin 2024.pdf |
HHSS 5/15/2025 3:15:00 PM |
HB 185 |
| HB 185 DOH Response Definition of Family Planning Services 05.09.25.pdf |
HHSS 5/15/2025 3:15:00 PM |
HB 185 |
| SB 134 A.2.pdf |
HHSS 5/15/2025 3:15:00 PM |
SB 134 |